Hyderabad Telangana, India

Laurus Labs Private Limited


USPTO Granted Patents = 66

% Expired Patents = 39.4


Forward Citations = 81

Loading Chart...
Loading Chart...

108 inventors (with patents filed for the assignee):

goldMedal Satyanarayana Chava (33 out of 36 patents)

silverMedal Venkata Sunil Kumar Indukuri (26 out of 26 patents)

bronzeMedal Ravindra Babu Bollu (12 out of 12 patents)

4.  Ram Thaimattam (12 out of 14 patents)

5.  Seeta Ramanjaneyulu Gorantla (10 out of 16 patents)

6.  Uma Maheswer Rao Vasireddi (9 out of 9 patents)

7.  Uma Maheswar Rao Vasireddi (9 out of 9 patents)

8.  Seeta Rama Anjaneyulu Gorantla (9 out of 9 patents)

9.  Sanjay Kumar Dehury (9 out of 10 patents)

10.  Kameswar Rao Chivukula (9 out of 9 patents)

11.  Srihari Raju Kalidindi (8 out of 8 patents)

12.  Venkata Lakshmi Narasimha Rao Dammalapati (7 out of 12 patents)

13.  Venkata S Indukuri (7 out of 7 patents)

14.  Seeta Raman Gorantla (7 out of 7 patents)

15.  Sivarami Reddy Yasam (6 out of 6 patents)


Core Competencies:
Tezacaftor
Bictegravir
Dapagliflozin
Nilotinib
Ivacaftor
SGLT2 Inhibitors
Pazopanib
Darunavir
Enzalutamide
Carfilzomib
Polymorphs
Tenofovir

66 patents:

Laurus Labs Private Limited, headquartered in Hyderabad, Telangana, specializes in the development and manufacture of pharmaceutical products. The company focuses on a range of therapeutic areas, particularly in the fields of oncology and infectious diseases. Its core technology topics include advanced compounds such as Tezacaftor, Bictegravir, and Dapagliflozin, among others. Laurus Labs is committed to innovation in pharmaceutical processes, contributing significantly to the global healthcare landscape through its research and development efforts.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Laurus Labs Private Limited
66 Patents

#1 in Hyderabad Telangana

#28 in India

#11,150 in the World

Hyderabad Telangana, IN
Hyderabad Telangana, India
Forward Citations = 81

108 inventors:

Please report any incorrect information to [email protected]
Loading…